Amalgamated Bank’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,644
Closed -$979K 2024
2025
Q4
$979K Buy
9,644
+63
+0.7% +$5.06K 0.01% 1072
2025
Q3
$524K Sell
9,581
-159
-2% -$7.94K ﹤0.01% 1293
2025
Q2
$518K Sell
9,740
-913
-9% -$46.4K ﹤0.01% 1261
2025
Q1
$461K Buy
10,653
+47
+0.4% +$2.38K ﹤0.01% 1287
2024
Q4
$596K Sell
10,606
-28
-0.3% -$1.74K ﹤0.01% 1242
2024
Q3
$724K Sell
10,634
-303
-3% -$17.1K 0.01% 1169
2024
Q2
$462K Buy
10,937
+284
+3% +$15.6K ﹤0.01% 1326
2024
Q1
$736K Sell
10,653
-18,535
-64% -$1.17M 0.01% 1166
2023
Q4
$2.16M Sell
29,188
-3,703
-11% -$243K 0.02% 882
2023
Q3
$2.24M Buy
32,891
+2,011
+7% +$171K 0.02% 832
2023
Q2
$2.9M Buy
30,880
+1,453
+5% +$113K 0.02% 719
2023
Q1
$2M Sell
29,427
-4,376
-13% -$281K 0.02% 865
2022
Q4
$1.67M Buy
33,803
+485
+1% +$19.8K 0.01% 957
2022
Q3
$1.08M Buy
33,318
+434
+1% +$17.9K 0.01% 1080
2022
Q2
$1.29M Buy
32,884
+13,774
+72% +$737K 0.01% 1047
2022
Q1
$1.34M Buy
19,110
+3,722
+24% +$272K 0.01% 1092
2021
Q4
$1.2M Buy
15,388
+4,871
+46% +$430K 0.01% 1157
2021
Q3
$1M Sell
10,517
-1,655
-14% -$175K 0.01% 1239
2021
Q2
$1.51M Buy
12,172
+4,993
+70% +$596K 0.01% 1086
2021
Q1
$946K Sell
7,179
-418
-6% -$57.2K 0.04% 608
2020
Q4
$1.01M Sell
7,597
-112
-1% -$13.5K 0.04% 532
2020
Q3
$786K Sell
7,709
-117
-1% -$10.1K 0.03% 580
2020
Q2
$680K Sell
7,826
-28,421
-78% -$2.27M 0.03% 643
2020
Q1
$2.1M Sell
36,247
-794
-2% -$64.5K 0.05% 336
2019
Q4
$3.43M Buy
37,041
+4,593
+14% +$404K 0.06% 282
2019
Q3
$2.93M Buy
32,448
+4,187
+15% +$477K 0.06% 289
2019
Q2
$3.34M Buy
28,261
+974
+4% +$98.1K 0.08% 236
2019
Q1
$2.36M Buy
27,287
+500
+2% +$42.6K 0.06% 317
2018
Q4
$1.69M Buy
26,787
+10,399
+63% +$714K 0.05% 388
2018
Q3
$1.29M Sell
16,388
-11,606
-41% -$757K 0.03% 548
2018
Q2
$1.67M Buy
27,994
+12,295
+78% +$662K 0.04% 475
2018
Q1
$633K Sell
15,699
-299
-2% -$14.6K 0.02% 856
2017
Q4
$841K Buy
15,998
+1,034
+7% +$55.2K 0.02% 779
2017
Q3
$705K Buy
14,964
+845
+6% +$34K 0.02% 812
2017
Q2
$499K Buy
14,119
+1,162
+9% +$35.9K 0.02% 947
2017
Q1
$306K Sell
12,957
-13
-0.1% -$258 0.02% 1119
2016
Q4
$173K Buy
12,970
+1,959
+18% +$31.6K 0.01% 1409
2016
Q3
$204K Buy
11,011
+782
+8% +$13.8K 0.01% 1259
2016
Q2
$213K Buy
10,229
+148
+1% +$1.11K 0.01% 1217
2016
Q1
$68K Buy
+10,081
New +$64.5K 0.01% 1245
2015
Q4
Sell
-10,052
Closed -$181K 1225
2015
Q3
$181K Buy
10,052
+854
+9% +$19.6K 0.02% 1172
2015
Q2
$274K Buy
+9,198
New +$231K 0.03% 1033
2015
Q1
Sell
-8,088
Closed -$222K 936
2014
Q4
$222K Buy
+8,088
New +$197K 0.03% 750

Other funds holding EXAS

Amalgamated Bank's EXAS Position: Q1 2026 in Review

Amalgamated Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,644 shares — an estimated $979K sold.

Amalgamated Bank first reported a position in EXAS in Q4 2014 and held it in 43 quarters. The position peaked at $3.43M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Amalgamated Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 9,644 Exact Sciences shares in Q1 2026, an estimated $979K.
  • Amalgamated Bank first reported a position in Exact Sciences in Q4 2014 and held it in 43 quarters.
  • Amalgamated Bank's Exact Sciences position peaked at $3.43M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.